September 22-25, 2026
Hynes Convention CenterBoston, USA Mario PhilipsCEO at Enovo LifesciencesSpeaker
Profile
Mario Philips, based in Belgium, is formerly the CEO of Polyplus, a leading provider of upstream solutions for cell and gene therapies, overseeing significant organic growth and strategic acquisitions until its ultimate €2.4 billion sale to Sartorius Stedim Biotech. He has previously held executive positions at Danaher/Pall Biotech, a leading life sciences and bioprocess company and ATMI Life Sciences, a global technology company and leader in single-use bioprocess solutions.
Agenda Sessions
Discussion 3 - Investors Perspectives 'Navigating Economic Uncertainty and its impact on Biopharma'
, 3:55pmView SessionDiscussion 3 - Investors Perspectives 'Navigating Economic Uncertainty and its impact on Biopharma'
, 4:30pmView Session